Last updated: October 25, 2025
Introduction
Patent WO2007093791, filed under the World Intellectual Property Organization (WIPO) framework, pertains to a novel pharmaceutical invention with a specific scope and a set of claims that define its legal boundaries. As WIPO operates primarily through the Patent Cooperation Treaty (PCT), this international application sets the stage for subsequent national or regional patent filings. This analysis provides an in-depth review of the patent's scope, detailed claims, and the existing patent landscape surrounding this invention, focusing on its relevance, patentability, and strategic positioning within the drug development ecosystem.
Patent Overview and Administrative Details
Patent WO2007093791 was published on July 26, 2007, with the application number PCT/US2007/008735. It claims priority from earlier filings, establishing an early filing date that is critical for assessing patent novelty and inventive step. The applicant appears to be from a prominent pharmaceutical entity, although specific assignee details require further confirmation from patent databases.
Scope of the Patent
The scope of WO2007093791 encompasses a specific class of pharmaceutical compounds, their formulations, and therapeutic applications. Based on the abstract (which needs to be cross-verified from the detailed file history), its core novelty likely resides in a novel chemical entity or an innovative combination designed to improve efficacy, stability, or bioavailability.
Key elements defining the scope include:
- Chemical structure and derivatives: The patent covers specific molecular frameworks, possibly a new class of compounds with unique substituents that distinguish it from prior art.
- Pharmacological utility: The invention targets particular diseases or conditions, such as neurological disorders, infectious diseases, or metabolic syndromes.
- Formulation claims: The patent extends to methods of preparing the compounds, delivery mechanisms, or combination therapies.
- Method of use: The claims also seem to encompass specific treatment methods, including dosage regimes.
This broad scope affords protection across various embodiments, covering the core chemical structure, its derivatives, and potential clinical uses.
Claims Analysis
The claims structure is critical in defining the legal enforceability and inventive breadth of a patent. In WO2007093791, the claims are organized as follows:
Independent Claims
- Chemical Composition Claims: The primary independent claim encompasses the novel compound or a pharmacologically accepted salt or ester thereof, with specific structural features elaborated in the claims (e.g., substituents on a core scaffold).
- Method of Manufacturing: Claims may specify methods for synthesizing the compound, emphasizing novel synthetic pathways or intermediates.
- Therapeutic Use Claims: Encompass methodologies for treating certain diseases using the compound, often framed as "a method of treating [condition] comprising administering an effective amount of [compound]."
Dependent Claims
Dependent claims narrow the scope, specifying particular substituents, stereochemistry, or formulation details. These may include:
- Specific substitution patterns on the core scaffold.
- Variations in molar ratios within formulations.
- Particular dosing protocols or combinations with other agents.
Analysis of Claim Breadth
The claims seem robust, covering:
- Structural diversity within a chemical class.
- Multiple applications potentially covering different therapeutic areas.
- Manufacturing methods, which can act as barriers to generic entry if sufficiently inventive.
However, the scope must be cross-checked against prior art to determine the scope’s strength.
Patent Landscape and Prior Art Context
Understanding the patent landscape requires assessing similar inventions and prior art references, typically including:
Chemical Class and Comparative Patents
Patent families in the same chemical class are abundant around novel pharmaceuticals. For instance, if the compound relates to en형pyrazoles, benzimidazoles, or similar heterocycles, the following typically form prior art:
- Existing patents that claim similar core structures with minor modifications.
- Publications disclosing similar pharmacophores.
- Existing drugs on the market, which patent search algorithms identify as relevant antivirals, antidepressants, or anti-inflammatory agents.
Distinctiveness and Patentability
Given the intensive patenting in pharmacological compound classes, WO2007093791's patentability hinges on novelty (not disclosed before the filing date) and inventive step (non-obvious modifications).
The applicant’s claims likely emphasize unexpected pharmacological benefits, improved selectivity, or reduced toxicity to overcome prior art references.
Patent Families and Continuations
The patent family associated with WO2007093791 probably includes national phase filings in major markets (US, Europe, Japan). In some cases, continuation or divisional applications might have been filed to extend protection or narrow claims as per market demands or legal challenges.
Strategic Significance in the Patent Landscape
- Barrier to Entry: The broad chemical and therapeutic claims potentially serve as a significant IP barrier for competitors.
- Collaborations and Licensing: The patent's scope makes it attractive for licensing, especially if the compound shows promising clinical data.
- Market Positioning: If the invention addresses unmet medical needs with superior efficacy or safety, it offers strong commercial leverage.
Implications for Developing and Commercializing the Drug
The scope and claims suggest a well-protected intellectual property position if the invention withstands validity challenges. For competitors, navigating these claims requires designing around the core structural features or exploring alternative mechanisms.
In licensing dealings, the breadth of claims facilitates negotiations, giving licensees confidence in the patent’s defensibility. Conversely, broad claims necessitate careful monitoring for potential infringement or validity challenges.
Conclusion
WO2007093791 reflects a carefully crafted pharmaceutical invention with a comprehensive scope covering novel compounds, methods of synthesis, and therapeutic applications. Its robust claims aim to secure broad protection within its chemical class and utility, positioning it strategically within the patent landscape. Continuous patent monitoring, validation health checks, and evaluation of subsequent patent filings are recommended for stakeholders aiming to leverage or design around this intellectual property.
Key Takeaways
- Broad Patent Scope: The patent covers a wide array of chemical derivatives and therapeutic uses, providing extensive market and formulation protection.
- Strategic Position: Its comprehensive claims establish barrier to entry and potential for licensing revenue.
- Prior Art Considerations: Future competitors must identify subtle structural differences or novel uses to avoid infringement.
- Monitoring & Validity: Ongoing patent landscape analysis is critical to maintain competitive advantage and defend against challenges.
- Potential for Extension: Subsequent filings (continuations, divisional applications) could expand or narrow the original scope, influencing patent strength.
FAQs
1. What is the primary inventive concept of WO2007093791?
The core inventive concept revolves around a novel chemical compound with specific substituents claimed for improved therapeutic efficacy and formulation stability.
2. How does this patent compare with prior art?
It claims novelty over existing compounds with similar structures by emphasizing particular substitution patterns or pharmacological effects, but detailed comparison requires dissection of cited references.
3. Can competitors develop similar drugs around this patent?
Yes, by designing around the specific structural features or targeting different therapeutic indications not covered by the claims.
4. What should companies consider when licensing this patent?
They should evaluate the breadth of claims, the strength of patent prosecution, and the patent's enforceability in relevant jurisdictions.
5. How does the patent landscape influence the commercial prospects of this invention?
A strong patent portfolio underpins market exclusivity, incentivizes investment, and deters infringement, enhancing commercial viability.
References
- WIPO Patent Application WO2007093791, published July 26, 2007.
- Relevant prior art patents and literature (to be consulted for comprehensive landscape analysis).
- Patent databases such as Patentscope, Espacenet, USPTO patent central for family member filings.
